Comparative Pharmacology
Head-to-head clinical analysis: ADVIL LIQUI GELS versus INDICLOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ADVIL LIQUI GELS versus INDICLOR.
ADVIL LIQUI-GELS vs INDICLOR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Non-selective cyclooxygenase (COX-1 and COX-2) inhibitor, reducing prostaglandin synthesis and thereby decreasing inflammation, pain, and fever.
Alkylating agent that crosslinks DNA, inhibiting DNA replication and transcription.
200–400 mg orally every 4–6 hours as needed; maximum 1200 mg/day.
INDICLOR is not a recognized drug; no standard dosing available.
None Documented
None Documented
1.8 to 2.5 hours. The short half-life supports dosing every 4 to 6 hours for acute pain and fever.
Terminal elimination half-life is 12 hours (range 10-15 hours) in patients with normal renal function; prolonged in renal impairment (up to 25 hours in severe cases).
Renal excretion of metabolites and conjugates accounts for approximately 90% of an administered dose. Less than 1% is excreted unchanged. Biliary/fecal elimination accounts for about 10%.
Primarily renal excretion (approximately 70% unchanged drug); biliary/fecal excretion accounts for about 10-15% as metabolites.
Category C
Category C
NSAID
NSAID